Brad S. Kahl
机构：Barnes-Jewish Hospital, Washington University in St. Louis, Jewish Hospital · ORCID：0000-0003-0459-6609
发表论文 908 篇 · 总被引 28616 次 · h-index 75
代表论文
- Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 (2025 · Journal of Clinical Oncology · 被引 27)
- NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026 (2026 · Journal of the National Comprehensive Cancer Network · 被引 8)
- Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma (2025 · Blood Advances · 被引 8)
- Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826 (2025 · Blood · 被引 8)
- Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study (2025 · Blood · 被引 7)
- Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma (2026 · Blood · 被引 6)